BACKGROUND: Brain oxygen (PbtO2) monitoring can help guide care of poor-grade aneurysmal subarachnoid hemorrhage (aSAH) patients. The relationship between PbtO2-directed therapy and long-term outcome is unclear. We hypothesized that responsiveness to PbtO2-directed interventions is associated with outcome. METHODS: Seventy-six aSAH patients who underwent PbtO2 monitoring were included. Long-term outcome [Glasgow Outcome Score-Extended (GOS-E) and modified Rankin Scale (mRS)] was ascertained using the social security death database and structured telephone interviews. Univariate and multivariate regression were used to identify variables that correlated with outcome. RESULTS: Data from 64 patients were analyzed (12 were lost to follow-up). There were 530 episodes of compromised PbtO2 (<20 mmHg) during a total of 7,174 h of monitor time treated with 1,052 interventions. Forty-two patients (66 %) survived to discharge. Median follow-up was 8.5 months (range 0.1-87). At most recent follow-up 35 (55 %) patients were alive, and 28 (44 %) had a favorable outcome (mRS ≤3). In multivariate ordinal regression analysis, only age and response to PbtO2-directed intervention correlated significantly with outcome. Increased age was associated with worse outcome (coeff. 0.8, 95 % CI 0.3-1.3, p = 0.003), and response to PbtO2-directed intervention was associated with improved outcome (coeff. -2.12, 95 % CI -4.0 to -0.26, p = 0.03). Patients with favorable outcomes had a 70 % mean rate of response to PbtO2-directed interventions whereas patients with poor outcomes had a 45 % response rate (p = 0.005). CONCLUSIONS: Response to PbtO2-directed intervention is associated with improved long-term functional outcome in aSAH patients.
BACKGROUND: Brain oxygen (PbtO2) monitoring can help guide care of poor-grade aneurysmal subarachnoid hemorrhage (aSAH) patients. The relationship between PbtO2-directed therapy and long-term outcome is unclear. We hypothesized that responsiveness to PbtO2-directed interventions is associated with outcome. METHODS: Seventy-six aSAH patients who underwent PbtO2 monitoring were included. Long-term outcome [Glasgow Outcome Score-Extended (GOS-E) and modified Rankin Scale (mRS)] was ascertained using the social security death database and structured telephone interviews. Univariate and multivariate regression were used to identify variables that correlated with outcome. RESULTS: Data from 64 patients were analyzed (12 were lost to follow-up). There were 530 episodes of compromised PbtO2 (<20 mmHg) during a total of 7,174 h of monitor time treated with 1,052 interventions. Forty-two patients (66 %) survived to discharge. Median follow-up was 8.5 months (range 0.1-87). At most recent follow-up 35 (55 %) patients were alive, and 28 (44 %) had a favorable outcome (mRS ≤3). In multivariate ordinal regression analysis, only age and response to PbtO2-directed intervention correlated significantly with outcome. Increased age was associated with worse outcome (coeff. 0.8, 95 % CI 0.3-1.3, p = 0.003), and response to PbtO2-directed intervention was associated with improved outcome (coeff. -2.12, 95 % CI -4.0 to -0.26, p = 0.03). Patients with favorable outcomes had a 70 % mean rate of response to PbtO2-directed interventions whereas patients with poor outcomes had a 45 % response rate (p = 0.005). CONCLUSIONS: Response to PbtO2-directed intervention is associated with improved long-term functional outcome in aSAH patients.
Authors: Mauro Oddo; Joshua M Levine; Larami Mackenzie; Suzanne Frangos; François Feihl; Scott E Kasner; Michael Katsnelson; Bryan Pukenas; Eileen Macmurtrie; Eileen Maloney-Wilensky; W Andrew Kofke; Peter D LeRoux Journal: Neurosurgery Date: 2011-11 Impact factor: 4.654
Authors: A K Gupta; P J Hutchinson; P Al-Rawi; S Gupta; M Swart; P J Kirkpatrick; D K Menon; A K Datta Journal: Anesth Analg Date: 1999-03 Impact factor: 5.108
Authors: Leif-Erik Bohman; Gregory G Heuer; Lukascz Macyszyn; Eileen Maloney-Wilensky; Suzanne Frangos; Peter D Le Roux; Andrew Kofke; Joshua M Levine; Michael F Stiefel Journal: Neurocrit Care Date: 2011-06 Impact factor: 3.210
Authors: Ross P Martini; Steven Deem; N David Yanez; Randall M Chesnut; Noel S Weiss; Stephen Daniel; Michael Souter; Miriam M Treggiari Journal: J Neurosurg Date: 2009-10 Impact factor: 5.115
Authors: Levin Häni; Mario D Ropelato; Franca Wagner; Andreas Nowacki; Nicole Söll; Matthias Haenggi; Andreas Raabe; Werner J Z'Graggen Journal: Neurocrit Care Date: 2020-12-16 Impact factor: 3.210
Authors: Nudrat Tasneem; Edgar A Samaniego; Connie Pieper; Enrique C Leira; Harold P Adams; David Hasan; Santiago Ortega-Gutierrez Journal: Crit Care Res Pract Date: 2017-05-07